BAYER AKTIENGESELLSCHAFT 3
3 · Metagenomi, Inc. · Filed Feb 15, 2024
Insider Transaction Report
Form 3
BAYER HEALTHCARE LLC
10% Owner
Holdings
Series A-1 Convertible Preferred Stock
→ Common Stock (1,770,888 underlying)Series A-4 Convertible Preferred Stock
→ Common Stock (1,180,592 underlying)Series B Convertible Preferred Stock
→ Common Stock (589,662 underlying)Series B-1 Convertible Preferred Stock
→ Common Stock (509,855 underlying)
Footnotes (5)
- [F1]Each share of Series A-1 Convertible Preferred Stock will automatically convert into shares of common stock upon the closing of the Issuer's Initial Public Offering ("IPO"). Each share of Series A-1 Convertible Preferred Stock has no expiration date.
- [F2]The securities reported are held directly by Bayer HealthCare LLC, a Delaware limited liability company, which is controlled by Bayer US Holding LP ("BUSH LP"), a Delaware limited partnership. Bayer World Investments B.V. ("BWI"), a Dutch private limited company, is the general partner of BUSH LP. BWI is an indirect, wholly owned subsidiary of Bayer Aktiengesellschaft, a publicly-held German stock corporation. Accordingly, Bayer Aktiengesellschaft may be deemed to be an indirect beneficial owner of the shares beneficially owned directly by Bayer HealthCare LLC.
- [F3]Each share of Series A-4 Convertible Preferred Stock will automatically convert into shares of common stock upon the closing of the Issuer's IPO. Each share of Series A-4 Convertible Preferred Stock has no expiration date.
- [F4]Each share of Series B Convertible Preferred Stock will automatically convert into shares of common stock upon the closing of the Issuer's IPO. Each share of Series B Convertible Preferred Stock has no expiration date.
- [F5]Each share of Series B-1 Convertible Preferred Stock will automatically convert into shares of common stock upon the closing of the Issuer's IPO. Each share of Series B-1 Convertible Preferred Stock has no expiration date.